immunohistolog evalu effect cyclosporin treatment lichen planu immun infiltr cutan immun infiltr lesion patient sever extens lichen planu recent onset day oral low-dos cyclosporin therapi mg/kg/day therapi abnorm bandlik cellular infiltr papillari dermi cell preval cell lymphocyt marker activ hla-dr antigen interleukin receptor mani langerhan cell dermal infiltr day cyclosporin therapi dramat decreas total number cell correspond decreas interleukin receptor-posit cell antigen-pres cell chang concurr clinic improv result compat hypothesi inhibit cell cyclosporin drug therapeut action interact antigen-pres cell cell import pathogenesi lichen planu 